There are numerous upstream regulators of TP53; however, key in MPN are MDM2 and MDM4, which inhibit TP53 transcriptional function by facilitating nuclear export and by inducing ubiquitin-mediated degradation. This evidence concerns the gene TP53 and myeloproliferative neoplasm.